Related Experiment Video
Updated: Jan 14, 2026

Production and Use of Lentivirus to Selectively Transduce Primary Oligodendrocyte Precursor Cells for In Vitro Myelination Assays
Published on: January 12, 2015
Med20 regulates myelination in the peripheral nervous system by modulating ferroptosis of Schwann cells
Wenyi Yang1, Xiang Chen1, Chunyan Yang1
1State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Department of Obstetrics, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China.
Abstract:
Myelin sheath is essential for the maintenance of neural system functions. The mediator complex (MED) is associated with neurodegenerative diseases. Mutation of the MED subunit Med20 leads to abnormal brain development, but whether Med20 modulates myelination remains unknown. In this study, we report that Med20 is an important modulator of myelination in the peripheral nervous system. Loss of Med20 in Schwann cells (SCs) induces ferroptosis, thus impairing myelination. The functions of Med20 in SCs are mediated by its downstream target DDB1. DDB1 controls SC ferroptosis by regulating Hmox1 through a "DDB1-UHRF1-BACH1-Hmox1" transcription regulation axis and its direct interaction and subsequent simultaneous ubiquitination of the HO-1 protein. HO-1 inhibitor ZnPP or ferroptosis inhibitor Fer-1 is sufficient and efficient for antagonizing ferroptosis in SCs and restoring myelination in Med20-deficient mice. The results of our study reveal that Med20 is an important regulator in the network that controls myelination in the peripheral nervous system.
Insights
Med20 is crucial for peripheral nervous system myelination. Its loss in Schwann cells triggers ferroptosis, impairing myelin. Inhibiting ferroptosis restores myelination in Med20-deficient mice.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Myelin sheath is vital for neural function.
- Mediator complex (MED) is linked to neurodegenerative diseases.
- Med20 mutations cause brain developmental issues, but its role in myelination is unclear.
Purpose of the Study:
- Investigate Med20's role in peripheral nervous system myelination.
- Determine the molecular mechanisms by which Med20 regulates myelination.
Main Methods:
- Studied Med20 function in Schwann cells (SCs).
- Analyzed the downstream targets and regulatory pathways of Med20.
- Utilized ferroptosis inhibitors (Fer-1) and HO-1 inhibitors (ZnPP) in Med20-deficient mice models.
Main Results:
- Med20 loss in SCs induces ferroptosis, leading to impaired myelination.
- Med20's function in SCs is mediated by DDB1.
- DDB1 regulates SC ferroptosis via the "DDB1-UHRF1-BACH1-Hmox1" axis and HO-1 ubiquitination.
- Fer-1 and ZnPP treatments restored myelination in Med20-deficient mice.
Conclusions:
- Med20 is a key regulator of myelination in the peripheral nervous system.
- Med20 controls SC ferroptosis through the DDB1-dependent pathway.
- Targeting ferroptosis pathways offers a potential therapeutic strategy for myelin repair.
Related Concept Videos
Nervous Tissue: Myelin
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Neurogenesis and Regeneration of Nervous Tissue

